NBS Financial Facts
Net loss attributable to NeoStem, Inc. common shareholders: -6.88MResearch and development: 2.63M
See Full Income Statement
Accounts payable: 3.25M
Deferred income taxes: 1.08M
See Full Balance Sheet
Neostem (NBS) Earnings
|
Expand Research on NBS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -20.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | 0.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/14/12 | Q312 | -$0.06 | -$0.05 | -$0.01 | $4.4M | $3.5M | N/A |  | | Details | |
| 11/11/11 | Q311 | -$0.13 | -$0.11 | -$0.02 | $17.8M | $22.01M | N/A | | | Details | |
8/15/11  |
Q211 | -$0.13 | -$0.09 | -$0.04 | $18.5M | $23.77M | N/A | | | Details |
